Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared as a global emergency in January 2020 due to its pandemic outbreak. To examine this Coronavirus disease 2019 (COVID-19) effects various data are being generated through different platforms. This study was focused on the clinical data of COVID-19 which relied on python programming. Here, we proposed a machine learning approach to provide a insights into the COVID-19 information. PySpark is a machine learning approach which also known as Apache spark an accurate tool for the searching of results with minimum time intervals as compare to Hadoop and other tools. World Health Organization (WHO) started gathering corona patients’ data from last week of the February 2020. On March 11, 2020, the WHO declared COVID-19 a global pandemic. The cases became more evident and common after mid-March. This paper used the live owid (our world in data) dataset and will analyse and find out the following details on the live COVID-19 dataset. (1) The daily Corona virus scenario on various continents using PySpark in microseconds of Processor time. (2) After the various antibodies have been implemented, how they impact new cases on a regular basis utilizing various graphs. (3) Tabular representation of COVID-19 new cases in all the continents.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This data were taken from public data base
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author Approvals All authors have seen and approved the manuscript, and that it hasn’t been accepted or published elsewhere
Authors have no competing interests to declare
Data Availability
https://github.com/owid/covid-19-data/blob/master/public/data
